© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Transforming the more common type A blood into type O could build up blood supplies and reduce shortages around the globe.
In a recent settlement, the state agreed to expand coverage of HCV treatment—but only to those with advanced liver scarring.
University of Washington School of Medicine specialist comments on study findings published in JAMA Network Open.
Advocates at the Global Liver Institute are declaring the liver disease a “hidden epidemic” across the globe.
A new study finds strong support for the harm reduction strategy among those most likely to use them.
The state is appealing a ruling that requires the prison system to properly treat inmates with the virus.
It’s the 24th state to declare an outbreak since mid-2016.
The Trump administration had proposed changing which meds were covered, including HIV and cancer drugs.
The popular weed killer has been the subject of several lawsuits over its potential health effects.
Responding to the increasing incidence of liver cancer in the United States
The proposal rolls back nondiscrimination policies of the Affordable Care Act, notably for transgender people and women who had abortions.
A recent article in The Seattle Times asks why.
The freezer section staples have been implicated in four major outbreaks over the past 20 years.
Four things you should know to be #HepAware.
Needle exchanges are being endorsed and legalized in a number of red states.
At the center of the lawsuit is Teva Pharmaceutical, slated to sell a generic version of the HIV prevention pill PrEP next year.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
